AME

Analyst Note: AMETEK, Inc. (AME)

Date: 2026-06-13 Current Price: $237.42

1. Structural Readiness

• State: Context-Only (Forming Coil)
• Aggressive/Pre-Breakout Entry: Not recommended as a standalone signal. The "Forming" state represents a partial readiness signal (historically ~69% success rate for breakouts from this state), but it lacks the confirmation of a breakout.
• Breakout Level: Pending confirmation.
• Current Price: $237.42.
• Extension: Not applicable (price is within the forming range, not extended above a breakout).
• ATR Context: Current ATR is 2.1% (sub-threshold). This indicates lower volatility than the historical "sweet spot" (4–6%), suggesting the market is currently in a consolidation phase rather than a high-velocity expansion.

2. Thesis Layer

• Primary Secular Thesis: Reshoring & Industrial Automation (Industrial Machinery & Components).
• Role & Directness: AME is a direct beneficiary as a "Quality Compounder" in this space. The company's Electronic Instruments Group (EIG) and Electromechanical Group (EMG) provide the precision motion control, thermal management, and analytical tools essential for advanced manufacturing and automation. The evidence highlights that their products are critical for "mission-critical applications" requiring maximum accuracy, stability, and repeatability (E6), which are the hallmarks of reshoring high-value manufacturing.
• Secondary Secular Thesis: Defense Modernization (Drones / UAS).
• Role & Directness: AME is a tertiary beneficiary here. The company has been selected to provide technologies for three UAV programs (one U.S., two NATO) (E5). While this provides a strong tailwind, the conviction weight is lower than the industrial automation thesis, as the defense exposure is specific to certain segments rather than the entire portfolio.
• Combined Exposure: The company is riding two structural waves. The industrial automation thesis provides the broad, recurring revenue base, while the defense modernization thesis offers a high-growth, government-backed acceleration vector. The combination suggests a robust defensive-offensive profile.

3. Business Overview

AMETEK, Inc. is a global enterprise developing and marketing a diverse portfolio of electronic instruments and electromechanical devices. The company operates through two primary segments:

• Electronic Instruments Group (EIG): A leader in advanced instruments for process, power, industrial, and aerospace markets. It supplies sophisticated tools for laboratory settings, ultra-precision manufacturing, medical diagnostics, and critical test and measurement tasks (E20, E26-E29).
• Electromechanical Group (EMG): A differentiated supplier of precision motion control solutions, highly engineered medical components, thermal management systems, specialty metals, and electrical interconnects (E21, E30-E34).

Financial & Operational Evidence (as of 2026-06-13):

• Record Growth: In Q1 2026, orders reached a record $2.2176 billion, a 23.3% increase year-over-year (E9).
• Backlog Strength: The backlog of unfilled orders stood at a record $3.8707 billion as of March 31, 2026, up 8.1% from the prior quarter (E10).
• Margin Expansion: Core operating margins were 31.4%, up 40 basis points year-over-year (E4). Segment operating margins increased to 28.2% in Q1 2026 (E11).
• Acquisition Strategy: The company has completed 15 acquisitions since 2021, totaling ~$1.8 billion in annualized sales. Recent integrations include FARO Technologies (July 2025) and LKC Technologies (Jan 2026), with a new definitive agreement to acquire First Aviation Services (April 2026) to expand MRO capabilities (E8, E13, E15, E22).
• Guidance: Management expects 2026 overall sales to be up high single digits, with organic sales increasing mid-single digits (E2). EPS is expected to be in the range of $7.94 to $8.14, representing 7-10% growth (E3).

4. Archetype and Conviction

• Archetype: Quality Compounder.
• Fit: AME fits this archetype through its consistent execution of an acquisition-led growth strategy, sustained margin expansion, and ability to generate strong operating cash flow. The company has posted record sales, operating income, and backlog in 2025 (E16), and continues this momentum into 2026.
• Valuation & Financial Spine:
• Forward consensus EPS for FY1 is $8.14, and FY2 is $8.81 (E37).
• At a current price of $237.42, the stock trades at approximately 29x FY1 consensus EPS. This valuation reflects the high quality of the compounder and the strong growth visibility provided by the record backlog.
• Conviction Stack:
• Thesis Strength: High. The dual exposure to reshoring and defense modernization provides a robust secular tailwind.
• Evidence Quality: High. The evidence base is comprehensive, citing record orders, margin expansion, and specific acquisition synergies.
• Structural Quality: High. The company demonstrates operational excellence with margin improvements and successful integration of recent acquisitions.
• Rerating Potential: Moderate to High. If the breakout occurs, the combination of record backlog and margin expansion could support a multiple expansion, though the current valuation is already rich.

5. Invalidations, Strengths, and Gaps

• What Would Strengthen: A confirmed breakout above the resistance level with high volume would confirm the "Active" state. Further evidence of margin expansion beyond the 31.4% core operating margin or an acceleration in defense order intake would strengthen the conviction.
• Gaps in Evidence:
• Customer Concentration: While international sales are strong (47.9%), specific exposure to any single large defense or industrial customer is not detailed.
• Integration Risks: While recent acquisitions are cited as positive, the long-term integration risk of the First Aviation acquisition (announced April 2026) is not yet fully realized in the financials.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: Medium Key evidence: Record Q1 2026 orders of $2.2B (up 23% YoY) and record backlog of $3.87B; Core operating margins expanded to 31.4% (up 40 bps); Management guidance for 2026 EPS growth of 7-10% and high single-digit sales growth. Key risks: Valuation compression if growth slows below guidance; Integration risks from recent and pending acquisitions (First Aviation); Geopolitical volatility impacting defense spending timelines. Sizing hint: Position size should reflect the "Forming" setup state; consider scaling in on a confirmed breakout rather than full entry at current levels. Expected path: Management expects continued organic growth driven by reshoring and defense modernization; the company is positioned to leverage its record backlog to drive revenue and margin expansion through 2026 and 2027. Expected horizon: 12 to 18 months for the thesis to fully play out through earnings cycles.